Results

Total Results: 5,243 records

Showing results for "stakeholder".
Users also searched for: quality

  1. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/prevehosp-reports-ig.pdf
    November 30, 2013 - AHRQ’s Safety Program for Nursing Homes: On-Time Preventable Hospital and ED Visits 1 On-Time Preventable Hospital and ED Visits: Reports AHRQ’s Safety Program for Nursing Homes: On-Time Preventable Hospital and ED Visits Training Slide 1: Introduction to Preventable Hospital and ED Visits Reports …
  2. www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/MOC-PIV-Field-Guide.pdf
    June 01, 2015 - Opportunities for Integrating MOC Part IV Requirements into PBRN Practices Opportunities for Integrating MOC Part IV Requirements into PBRN Practices JUNE 2015 Opportunities for Integrating MOC Part IV Requirements into PBRN Practices Prepared for: Agency for Healthcare Research and Quality U.…
  3. effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Tympanostomy Tubes in Children With Otitis Media Draft review available for public comment from July 20, 2016 to August 11, 2016. R…
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Tympanostomy Tubes in Children With Otitis Media Draft review available for public comment from July 20, 2016 to August 11, 2016. R…
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
    January 07, 2016 - Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy Comparative Effectiveness Review Disposition of Comments Report Research Review Titles: …
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - 1 Comparative Effectiveness Review Number 96 Primary Care Management of Abnormal Uterine Bleeding Executive Summary Background Abnormal uterine bleeding (AUB) is among the most common gynecologic complaints of reproductive-age women in ambulatory care settings. It is estimated to affect 11 to 13 percent of…
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_executive.pdf
    August 01, 2016 - Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review 1 Comparative Effectiveness Review Number 179 Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review Executive Summary Background Atherosclerotic renal artery stenosis (ARAS) is increasin…
  8. www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dxsafety-particpant-workbook.pdf
    February 04, 2022 - TeamSTEPPS for Improving Diagnosis Participant Workbook TeamSTEPPS® for Diagnosis Improvement Participant Workbook Participant Workbook This page is intentionally blank. Contents Introduction: TeamSTEPPS for Diagnosis Improvement ........................................................1 Module 1: Introducti…
  9. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/stpra/stpra.pdf
    March 01, 2012 - Proactive Risk Assessment of Surgical Site Infections in Ambulatory Surgery Centers Final Contract Report Proactive Risk Assessment of Surgical Site Infections in Ambulatory Surgery Centers Final Contract Report Proactive Risk Assessment of Surgical Site Infections in Ambulatory Surgery Centers Pre…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
    August 01, 2014 - 1 Comparative Effectiveness Review Number 137 Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update Executive Summary Background Autism spectrum disorder (ASD) is a neurodevelopmental disorder marked by impaired social communication and social interaction accompanied by atypica…
  11. Gout Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - 1 Comparative Effectiveness Review Number 176 Management of Gout Executive Summary Background and Objectives Gout is the most common form of inflammatory arthritis and is characterized by acute intermittent episodes of synovitis presenting with joint swelling and pain (referred to as acute gouty arthriti…
  12. Gout Executive-2016 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
    January 01, 2016 - 1 Comparative Effectiveness Review Number 158 Diagnosis of Gout Executive Summary Background Condition Gout is a form of inflammatory arthritis characterized by acute intermittent episodes of synovitis presenting with joint swelling and pain; the episodes are referred to as acute gouty arthritis flare…
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
    March 28, 2019 - CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults Draft review available for public comment from May 13, 201…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
    May 01, 2013 - 1 Comparative Effectiveness Review Number 110 Wireless Motililty Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: A Comparative Effectiveness Review Executive Summary Gastroparesis Definition and Prevalence Gastroparesis is a condition in which patients experience …
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
    January 01, 2007 - Layout 1 Background Depressive disorders such as major depressive disorder (MDD), dysthymia, and subsyndromal depression (including minor depression) may be serious disabling illnesses. MDD is the most prevalent, affecting more than 16 percent (lifetime) of U.S. adults. In 2000, the U.S. economic burden of depressiv…
  16. digital.ahrq.gov/sites/default/files/docs/citation/r01hs023837-gurses-final-report-2021.pdf
    January 01, 2021 - Care Transitions and Teamwork in Pediatric Trauma: Implications for HIT Design - Final Report Final Progress Report of “Care Transitions and Teamwork in Pediatric Trauma: Imp…
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
    January 01, 2014 - 1 Comparative Effectiveness Review Number 124 Meditation Programs for Psychological Stress and Well-Being Executive Summary Introduction Definition of Meditation The National Center for Complementary and Alternative Medicine defines meditation as a “mind-body” method. This category of complementary and …
  18. effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
    October 01, 2011 - Attention Deficit Hyperactivity Disorder: Executive Summary                                                                                                                                                                                                                                                       …
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - 1 Comparative Effectiveness Review Number 53 Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report Executive Summary Background Osteoporosis is a systemic skeletal disease characterized by decreasing bone mass and microarchitectural deterioration of bo…
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
    October 01, 2010 - Layout 1 Background Cystic fibrosis (CF) is the second most common life-shortening, childhood-onset genetic disease in the United States, affecting approximately 30,000 people in the Nation. The gene responsible for CF encodes the cystic fibrosis transmembrane regulator (CFTR) protein, which regulates sodium and chl…